Dr. Hiroto Bando is currently Senior Director, Global head of cell manufacturing strategy and Head of alliance strategy in Regenerative Medicine Unit at Takeda Pharmaceutical Industries. On top of his strong scientific expertise, since he has MBA and practical working experiences at corporate department at Takeda, his responsibility is strategic consideration to enter regenerative medicine field e.g. to identify internal capability gap to be enhanced for the success of business, and to consider the strategic collaboration with external partners who have the strong/advanced expertise related to new pre-clinical/clinical projects, innovative platform technologies, cell mfg. process development as well as cell mfg. capability. Now he is working at Takeda Boston, Cambridge, MA where headquarter of R&D is located.

Professional Experience
2016.8-Present Global Head of Cell Manufacturing Strategy, Regenerative Medicine Unit
Head of Strategic Alliance, Regenerative Medicine Unit
2014.7-2016.7 Research Manager, Innovation Technology Lab., CMC Center
2012.1-2014.6 Senior Director, Finance & Portfolio Management, CMSO Office
2007.4-2011.12 Franchise Coordinator, Strategic Product Planning
1997.4-2007.3 Assistant Research Head, Research Division
Education
2007.10-2009.9 MBA in Kenichi Ohmae Graduate School of Business
2004.2-2005.1 Post-doctoral researcher at College of Pharmacy in University of Texas
1997.3 PhD in Pharmaceutical Science, Graduate School of Pharmaceutical Science, Kyoto University